Disc Medicine to host webcast on APOLLO Phase 3 results for bitopertin in EPP

IRON•2026-10-18

Disc Medicine will host a corporate webcast on October 19, 2026, at 8 a.m. ET to discuss topline results from the APOLLO Phase 3 trial of bitopertin in erythropoietic protoporphyria.

Disc Medicine to host webcast on APOLLO Phase 3 results for bitopertin in EPP

1. Webcast details

Related News

Ballard Power Systems announces Q3 results conference call

Asia’s old-economy sectors offer investment opportunities beyond AI, Manishi Raychaudhuri says

Nasdaq trade halt continues, news pending at 3:28 a.m.

Nasdaq trade halt continues; reason not available at 03:28 am

Nasdaq trade halt continues; reason not available at 3:28 a.m.